PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.

Detalles Bibliográficos
Autores principales: Krupitsky, E., Mukhametshina, E., Samsonov, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616244/
http://dx.doi.org/10.1093/ijnp/pyw041.308
_version_ 1783266735862841344
author Krupitsky, E.
Mukhametshina, E.
Samsonov, M.
author_facet Krupitsky, E.
Mukhametshina, E.
Samsonov, M.
author_sort Krupitsky, E.
collection PubMed
description
format Online
Article
Text
id pubmed-5616244
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56162442017-11-27 PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction. Krupitsky, E. Mukhametshina, E. Samsonov, M. Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616244/ http://dx.doi.org/10.1093/ijnp/pyw041.308 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Krupitsky, E.
Mukhametshina, E.
Samsonov, M.
PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.
title PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.
title_full PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.
title_fullStr PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.
title_full_unstemmed PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.
title_short PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.
title_sort pm308. a phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –odelepran the treatment of alcohol addiction.
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616244/
http://dx.doi.org/10.1093/ijnp/pyw041.308
work_keys_str_mv AT krupitskye pm308aphase3multicenterrandomizeddoubleblindplacebocontrolledstudyoftheopioidreceptorantagonistodelepranthetreatmentofalcoholaddiction
AT mukhametshinae pm308aphase3multicenterrandomizeddoubleblindplacebocontrolledstudyoftheopioidreceptorantagonistodelepranthetreatmentofalcoholaddiction
AT samsonovm pm308aphase3multicenterrandomizeddoubleblindplacebocontrolledstudyoftheopioidreceptorantagonistodelepranthetreatmentofalcoholaddiction

Ejemplares similares